Located in Strasbourg (France), the BIOSYNEX Company was born in 2005 and specialises in the design and distribution of rapid tests (RDT). Biosynex is now the French market leader in this field.
Fast and easy to use, these tests are commercialized in France and in some 90 countries through local distributors. By targeting both the public and healthcare professionals, Biosynex provides concrete effective solutions to all the latest public health issues.
Since 2020, Biosynex has been at the forefront of the Covid-19 pandemic, offering innovative screening solutions (serology tests, antigen tests, self tests and PCR).
22 Boulevard Sébastien Brant, 67400 Illkirch-Graffenstaden – France
March 21, 2011Stock exchange(s)